Lv1
60 积分 2025-05-22 加入
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence
13小时前
已完结
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
13小时前
已完结
Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report
20天前
已完结
Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial
1个月前
已完结
Comparative Efficacy of PD-1 Inhibitor-Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II-IIIa NSCLC: A Real-World Retrospective Study
1个月前
已完结
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
1个月前
已完结
Tumor-informed ctDNA assay to predict outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with PD-1 inhibitor
1个月前
已完结
Biomarkers predictive of response to pembrolizumab in head and neck cancer
1个月前
已完结
A multicenter, single-arm, open study of neoadjuvant or conversion atezolizumab in combination with chemotherapy in resectable small cell lung cancer (Cohort Study)
1个月前
已完结
皖公网安备34019202002308
